Articles Tập 67 Số CĐ15 25/09/2026

CHARACTERISTICS AND TREATMENT OUTCOMES OF GASTROINTESTINAL BLEEDING SECONDARY TO PEPTIC ULCER DISEASE IN CHILDREN AGED 6–15 YEARS AT CAN THO CHILDREN'S HOSPITAL

Ly Van Vi, Le Thi Thuy Loan
DOI: 10.52163/yhc.v67iCD15.6822
54 Views
0 Downloads
Abstract

Objectives: To describe the clinical and subclinical characteristics and treatment outcomes of  pediatric patients (aged 6–15 years) diagnosed with UGIB due to peptic ulcer disease at Can Tho Children's Hospital from May 2024 to May 2026.

Subjects and methods: A prospective descriptive cohort study was conducted on 60 children diagnosed with UGIB secondary to peptic ulcer disease who met the inclusion and exclusion criteria at Can Tho Children's Hospital to May 2024 and May 2026. Eligible patients were consecutively enrolled throughout the study period. Data were collected prospectively using standardized case report forms from the time of hospital admission and patients were followed until hospital discharge.

Results: The mean age was 12.2 ± 2.5 years, and 76.7% of the patients were male. Melena was the most common reason for hospital admission (30%). Abdominal pain was the most common gastrointestinal symptom, occurring in 80% of the pediatric patients. Most cases of upper gastrointestinal bleeding were classified as mild (80%). Upper gastrointestinal endoscopy revealed that duodenal ulcers were the predominant lesions (96.7%); most ulcers were small (<1 cm, 65%) and solitary (70%). According to the Forrest classification, Forrest III ulcers accounted for the highest proportion (95%). The prevalence of confirmed Helicobacter pylori infection was 91.7%. Medical management was provided for 96.7% of the patients, all patients were discharged from the hospital, and no deaths were recorded.

Conclusion: Upper gastrointestinal bleeding secondary to peptic ulcer disease occurred predominantly in boys. Most cases of upper gastrointestinal bleeding were classified as mild.

References
[1]
[1] Kocic M, Rasic P, Marusic V et al. Age-specific causes of upper gastrointestinal bleeding in children. World J Gastroenterol. 2023 Dec 21;29(47):6095–6110. doi:10.3748/wjg.v29.i47.6095 PubMed PMID: 38186684; PubMed Central PMCID: PMC10768410. Google Scholar
[2]
[2] Châu Tố Uyên và cộng sự. Đặc điểm lâm sàng và nguyên nhân xuất huyết tiêu hóa trên qua nội soi tiêu hóa ở trẻ em tại bệnh viện Nhi Đồng 1. Tạp chí Y Học Thành phố Hồ chí Minh. 2025;28(9):188–195. doi:10.32895/hcjm.m.2025.09.22 Google Scholar
[3]
[3] Sahn B, M.P., Friedlander J. Gastrointestinal Hemorrhage, in Pediatric Gastrointestinal and Liver Disease. In: Vol. 5. Elsevier; 2016. p. 144-154.e4. Google Scholar
[4]
[4] Sur LM, Armat I, Sur G et al. Practical Aspects of Upper Gastrointestinal Bleeding in Children. Journal of Clinical Medicine. 2023 Apr 17;12(8):2921. doi:10.3390/jcm12082921 Google Scholar
[5]
[5] Phạm Võ Phương Thảo, Phan Thị Minh Tuyền , Mai Thế Dũng. Nghiên cứu đặc điểm lâm sàng và nguyên nhân xuất huyết tiêu hóa ở trẻ em. Tạp chí Y Dược học - Trường Đại học Y Dược Huế. 2022;12(2):67. doi:10.34071/jmp.2022.2.10 Google Scholar
[6]
[6] Bộ môn Nhi trường Đại học Y Dược Huế. Xuất huyết tiêu hóa. Giáo trình Đại học Nhi khoa. Huế: NXB Đại học Huế; 2019. Google Scholar
[7]
[7] Trần Ngọc Huy, Hà Văn Thiệu, Nguyễn Minh Ngọc. Đặc điểm biến chứng thường gặp loét dạ dày tá tràng ở trẻ em. Y học Thành phố Hồ Chí minh. 2018;22(3):179–84. Google Scholar
[8]
[8] Yu Y, Wang B, Yuan L et al. Upper Gastrointestinal Bleeding in Chinese Children: A Multicenter 10-Year Retrospective Study. Clin Pediatr (Phila). 2016 Aug;55(9):838–843. doi:10.1177/0009922815611642 PubMed PMID: 26467562. Google Scholar
[9]
[9] Nguyễn Thị Vân Trang, Tạ Quang Thành, Phạm Văn Đếm. Đặc điểm lâm sàng, cận lâm sàng và điều trị trẻ bị xuất huyết dạ dày tá tràng tại Khoa Nhi Bệnh viện Đa khoa Hà Đông. Tạp chí Y Học Việt Nam. 2025;553(1):223–227. doi:10.51298/vmj.v553i1.15255 Google Scholar
[10]
[10] Li R, Wang W, Ma Y et al. Analysis of risk factors for ulcer recurrence and upper gastrointestinal bleeding in children with peptic ulcer treated with Helicobacter pylori eradication therapy. Translational Pediatrics. 2023 Apr 19;12(4):618–630. doi:10.21037/tp-23-155 Google Scholar
[11]
[11] F G, Mi I, Mdl M et al. Trends in Upper Gastrointestinal Bleeding in Children: The Impact of Helicobacter pylori Infection and Non-Steroidal Anti-Inflammatory Drug Use. Antibiotics (Basel, Switzerland). 2024 Aug 10;13(8):752. doi:10.3390/antibiotics13080752 PubMed PMID: 39200052. Google Scholar
[12]
[12] El-Mazary AAM, Elfoly MA, Ahmed MF et al. Helicobacter Pylori Infection in a Group of Egyptian Children With Upper Gastro-Intestinal Bleeding. Gastroenterol Res. 2013 Jul 14;6(3):95–102. doi:10.4021/gr533e Google Scholar
[13]
[13] Homan M, Jones NL, Bontems P et al. Updated joint ESPGHAN/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023). Journal of Pediatric Gastroenterology and Nutrition. 2024 Sep;79(3):758–85. doi:10.1002/jpn3.12314 Google Scholar
[14]
[14] Nguyen TC, Tang NLC, Le GKN et al. Helicobacter pylori Infection and Peptic Ulcer Disease in Symptomatic Children in Southern Vietnam: A Prospective Multicenter Study. Healthcare (Basel). 2023 Jun 5;11(11):1658. doi:10.3390/healthcare11111658 PubMed PMID: 37297795; PubMed Central PMCID: PMC10253129. Google Scholar